Sort
3,198 grants matching “mrna vaccine”
The role of fungal adhesins in the modulation of the innate immune response
$120,150Duncan McNicol Kuhn · Whitehead Institute For Biomedical Res · K08 · FY2007 · AI
The role of fungal adhesins in the modulation of the innate immune response
$120,150Duncan McNicol Kuhn · Whitehead Institute For Biomedical Res · K08 · FY2008 · AI
Metabolic imprinting of dendritic cell fate and function in tissues
$118,275Bali Pulendran · Stanford University · R01 · FY2024 · AI
Metabolic imprinting of dendritic cell fate and function in tissues
$118,275Bali Pulendran · Stanford University · R01 · FY2023 · AI
Activation and Inhibition of Apoptotic Pathways by SV5
$117,425Pennsylvania State University-Univ Park · R01 · FY2003 · AI
Regulation of T Cell Immunity to Influenza by CD44
$117,231Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2008 · AI
Autophagy-mediated immune responses to oncolytic VSV
$117,072John Hiscott · Istituto Pasteur Italia Fondazione Cenci Bolognetti · R21 · FY2017 · CA
MECHANISMS OF IMMUNITY TO VIRAL VACCINES IN INFANCY
$116,766Stanford University · K23 · FY2002 · HD
Measuring High Affinity Mucosal Antibody Responses
$114,766Maria Virginia Pascual · Baylor Research Institute · U19 · FY2013 · AI
Cholera Pathogenesis, mucinase activity and motility
$114,668Morehouse School Of Medicine · R01 · FY2004 · AI
The role of regulatory T cell subsets and cytokines in the pathogenesis of hu....
$112,316Madhukar Rai · Banaras Hindu University · P50 · FY2011 · AI
SHIGA TOXIN EFFECTS ON GENE REGULATION
$112,050Tufts Medical Center · K08 · FY2000 · AI
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
$110,905Fang-Yi Su · Georgia Institute Of Technology · K99 · FY2023 · CA
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
$110,905Fang-Yi Su · Georgia Institute Of Technology · K99 · FY2024 · CA
Evaluation of iDMV-1.0: A Single Dose Self-Amplifying Vaccine for SARS-CoV-2
$110,871Devdoot Majumdar · University Of Vermont & St Agric College · P20 · FY2022 · GM
Pneumococcal Biofilms in Otitis Media
$110,669Allegheny-Singer Research Institute · R01 · FY2004 · DC
Targeted mRNA therapies treating ARDS
$110,623Zhengjie Zhou · University Of Chicago · K99 · FY2024 · HL
Targeted mRNA therapies treating ARDS
$110,623Zhengjie Zhou · University Of Chicago · K99 · FY2023 · HL
Molecular and Cellular Action of HLA Class II Molecules, Gen Risk Fctrs for VL
$110,524Shyam Sundar · Banaras Hindu University · P50 · FY2012 · AI
Influenza nucleoprotein interactions
$110,250Laura Lynn Newcomb · California State Univ San Bernardino · SC3 · FY2020 · GM
Influenza nucleoprotein interactions
$110,250Laura Lynn Newcomb · California State Univ San Bernardino · SC3 · FY2021 · GM
Influenza nucleoprotein interactions
$110,250Laura Lynn Newcomb · California State Univ San Bernardino · SC3 · FY2023 · GM
Influenza nucleoprotein interactions
$110,250Laura Lynn Newcomb · California State Univ San Bernardino · SC3 · FY2022 · GM
MECHANISMS OF IMMUNITY TO VIRAL VACCINES IN INFANCY
$110,062Stanford University · K23 · FY2001 · HD
MECHANISMS OF IMMUNITY TO VIRAL VACCINES IN INFANCY
$110,062Stanford University · K23 · FY2000 · HD